BLUEJAY DIAGNOSTICS, INC.

360 Massachusetts Avenue, Suite 203

Acton, MA 01720

 

November 5, 2021

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporate Finance

Washington, DC 20549

Attention: Tyler Howes

 

Re:

Bluejay Diagnostics, Inc.

Registration

Statement on Form S-1

Registration

No. 333-260029

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 of the Securities Act of 1933, as amended, Bluejay Diagnostics, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 P.M. (Eastern Time) on November 9, 2021, or as soon thereafter as possible on such date.

 

	Very truly yours,
	Bluejay Diagnostics, Inc.
	By:	/s/ Gordon Kinder
		Name:	Gordon Kinder
		Title:	Chief Financial Officer